copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical . . . Chemoradiotherapy (CRT) refers to the combined administration of both chemotherapy and radiotherapy as an anticancer treatment Over the years, CRT has become an established treatment for a diverse range of locally advanced solid tumours
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT . . . KEYTRUDA, in combination with chemotherapy, with or without bevacizumab, is indicated for the treatment of patients with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1 (CPS ≥1) as determined by an FDA-approved test
Definitive Chemoradiotherapy With Carboplatin for Squamous Cell . . . Definitive concurrent chemoradiotherapy (CRT) is considered the standard of care for organ preservation and is the only potentially curative therapy for surgically unresectable patients with stage III to IVb locally advanced squamous cell carcinoma of the head and neck
Pembrolizumab Plus CRT Approved for Cervical Cancer | AACR The U S Food and Drug Administration (FDA) has approved pembrolizumab (Keytruda) plus chemoradiotherapy (CRT) for the treatment of patients with stage III-IVA cervical cancer as assessed by the FIGO 2014 staging criteria Pembrolizumab is an immunotherapy known as an immune checkpoint inhibitor
Real-world outcomes with durvalumab after chemoradiotherapy in patients . . . Background: Based on the findings of the PACIFIC trial, consolidation durvalumab following platinum-based chemoradiotherapy (CRT) is a global standard of care for patients with unresectable, stage III non-small-cell lung cancer (NSCLC)